Zoetis appoints James Saccaro as CFO and COO in newly created combined role

Filed August 6, 2026 · Period ending August 6, 2026 · ~2 min read

Key Changes

• high

  James Saccaro appointed Executive VP, CFO and COO effective August 17, 2026, in newly created role combining finance leadership with oversight of Global Manufacturing and Supply operations.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
• high

  Saccaro brings 12 years of CFO experience from GE HealthCare (2023-2026) and Baxter International (2015-2023); will lead capital allocation, financial strategy, and investor engagement.

  Exhibit 99.1 view on EDGAR →
• high

  Outgoing CFO Wetteny Joseph transitions to advisory role through February 2027 to support handoff; departure not due to any disagreement with company on operations or accounting.

  Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →